Preclinical Activity of the Novel Anti-Prolactin Receptor (PRLR) Antibody-Drug Conjugate REGN2878-DM1 in PRLR-Positive Breast Cancers
新型抗催乳素受体 (PRLR) 抗体-药物偶联物 REGN2878-DM1 对 PRLR 阳性乳腺癌的临床前活性
期刊:Molecular Cancer Therapeutics
影响因子:5.3
doi:10.1158/1535-7163.MCT-16-0839
Marcus P Kelly, Carlos Hickey, Sosina Makonnen, Sandra Coetzee, Sumreen Jalal, Yu Wang, Frank Delfino, Jing Shan, Terra B Potocky, Ishita Chatterjee, Julian Andreev, Arthur Kunz, Christopher D'Souza, Jason T Giurleo, Thomas Nittoli, Pamela A Trail, Gavin Thurston, Jessica R Kirshner
